GL1X · GenesisL1 explorer

MolNFT v1 · #64410 · protein

Crystal structure of 1-(beta-D-glucopyranosyl)-4-substituted-1,2,3- triazoles in complex with glycogen phosphorylase

3G2H · Glycogen phosphorylase, muscle form: “Crystal structure of 1-(beta-D-glucopyranosyl)-4-substituted-1,2,3- triazoles in complex with glycogen…”. X-ray diffraction, 2 ligands (KOT, IMP), 13 pockets (best druggability 0.84). MolNFT v1…

PDB
3G2H
Type
protein
Length
807 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Glycogen phosphorylase, muscle form
EC
2.4.1.1
UniProt
P00489
Ligands
KOT, IMP
Pockets
13 · best druggability 0.84

Structure

x-ray diffraction · 1 distinct chain · 53% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGlycogen phosphorylase, muscle form (EC 2.4.1.1)protein80753% helix, 15% strandP00489

Ligands and binding sites

  • KOT · 1-beta-D-glucopyranosyl-4-phenyl-1H-1,2,3-triazole · ligand · chains A
  • IMP · Inosinic acid · ligand · chains A
  • DMS · Dimethyl sulfoxide · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

13 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13070.840.9443KOT, DMS
2700.690.9522empty
33890.670.8055empty
41110.530.8219empty
51790.500.7721IMP

Modifications

Observed in the structure: 1 modified (cofactor).

Compared structures

  • 3G2H · Crystal structure of 1-(beta-D-glucopyranosyl)-4-substituted-1,2,3-triazoles in complex… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.